UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 80 filers reported holding UROGEN PHARMA LTD in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,000 | -84.6% | 534 | -82.6% | 0.00% | – |
| Q4 2020 | $65,000 | +182.6% | 3,062 | +168.8% | 0.00% | – |
| Q3 2020 | $23,000 | -45.2% | 1,139 | -35.2% | 0.00% | – |
| Q2 2020 | $42,000 | +740.0% | 1,758 | +459.9% | 0.00% | – |
| Q1 2020 | $5,000 | -93.9% | 314 | -87.2% | 0.00% | – |
| Q4 2019 | $82,000 | +78.3% | 2,459 | +27.0% | 0.00% | – |
| Q3 2019 | $46,000 | -17.9% | 1,936 | +23.8% | 0.00% | – |
| Q2 2019 | $56,000 | – | 1,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |